Cinaciguat

CAS No. 329773-35-5

Cinaciguat ( —— )

Catalog No. M14089 CAS No. 329773-35-5

Cinaciguat (BAY 58-2667) is the first of a new class of soluble guanylate cyclase (sGC) activators in clinical development for acute decompensated heart failure.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 87 In Stock
5MG 132 In Stock
10MG 222 In Stock
25MG 376 In Stock
50MG 557 In Stock
100MG 795 In Stock
500MG 1602 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Cinaciguat
  • Note
    Research use only, not for human use.
  • Brief Description
    Cinaciguat (BAY 58-2667) is the first of a new class of soluble guanylate cyclase (sGC) activators in clinical development for acute decompensated heart failure.
  • Description
    Cinaciguat (BAY 58-2667) is the first of a new class of soluble guanylate cyclase (sGC) activators in clinical development for acute decompensated heart failure.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    sGC
  • Research Area
    Cardiovascular Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    329773-35-5
  • Formula Weight
    565.70
  • Molecular Formula
    C36H39NO5
  • Purity
    >98%(HPLC)
  • Solubility
    DMSO: 10 mM
  • SMILES
    OC(=O)CCCCN(CCC1=CC=CC=C1OCC1=CC=C(CCC2=CC=CC=C2)C=C1)CC1=CC=C(C=C1)C(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Mihai Gheorghiade1, et al. Eur J Heart Fail (2012) 14 (9): 1056-1066.
molnova catalog
related products
  • Tylosin tartrate

    Tylosin tartrate is a macrolide antibiotic approved for the control of mycoplasmosis in poultry.

  • Glucoalyssin

    The seeds of Sinapis alba L.

  • 1-Kestose

    1-Kestose shows significant anti-hydroxyl radical potential. 1-Kestose can promote intestinal Lactobacillus number and influence the microorganisms as well as the intestinal and systemic immune responses.